514336 GENESIS

Genesis IBRC India Share Price

 

 

Start SIP in GENESIS

Start SIP
Genesis IBRC India live price: ₹97. It opened at ₹97 vs previous close ₹99; intraday high/low: ₹97/₹97. The 50 & 200 DMA stand at ₹89.83/₹74.79.

Genesis IBRC India Performance

  • Today's Low
  • ₹97
  • Today's High
  • ₹97
  • 52 Week Low
  • ₹18
  • 52 Week High
  • ₹185
  • Open Price₹97
  • Previous Close₹99
  • Volume17
  • 50 DMA₹89.83
  • 100 DMA₹88.26
  • 200 DMA₹74.79

Investment Returns

  • Over 1 Month + 28.56%
  • Over 3 Month + 14.28%
  • Over 6 Month + 28.96%
  • Over 1 Year + 428.9%

Smart Investing Starts Here Start SIP with Genesis IBRC India for Steady Growth!

Invest Now

Genesis IBRC India Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -532.7
  • PEG Ratio
  • 11.6
  • Market Cap Cr
  • 126
  • P/B Ratio
  • 15.2
  • Average True Range
  • 4.15
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • 4.93
  • RSI
  • 62.14
  • MFI
  • 96.43

Genesis IBRC India Financials

Genesis IBRC India Technicals

EMA & SMA

Current Price
₹97.00
-1.98 (-2%)
pointer
  • Bearish Moving Average 6
  • Bullish Moving Average 10
  • 20 Day
  • ₹93.40
  • 50 Day
  • ₹89.83
  • 100 Day
  • ₹88.26
  • 200 Day
  • ₹74.79

Resistance and Support

98.98 Pivot Speed
  • R3 98.98
  • R2 98.98
  • R1 98.98
  • S1 98.98
  • S2 98.98
  • S3 98.98

Ratings

Master Rating

EPS Strenth

N/A

Price Strength

Buyer Demand

Group Rank

Genesis Ibrc India has an operating revenue of Rs. 4.38 Cr. on a trailing 12-month basis. Pre-tax margin of 0% needs improvement, ROE of 41% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. From an O'Neil Methodology perspective, the stock has an EPS Rank of 0 which is a POOR score indicating inconsistency in earnings, a RS Rating of 98 which is GREAT indicating the outperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 39 indicates it belongs to a strong industry group of Medical-Biomed/Biotech and a Master Score of C is fair but needs to improve. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Genesis IBRC India Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-02-14 Quarterly Results
2026-01-28 Preferential issue of shares
2025-11-14 Quarterly Results
2025-08-14 Quarterly Results
2025-05-29 Audited Results

Genesis IBRC India F&O

Genesis IBRC India Shareholding Pattern

11.33%
25.09%
63.58%

Genesis IBRC India FAQs

Genesis IBRC India share price is ₹97 As on 02 April, 2026 | 15:01

The Market Cap of Genesis IBRC India is ₹126.1 Cr As on 02 April, 2026 | 15:01

The P/E ratio of Genesis IBRC India is -532.7 As on 02 April, 2026 | 15:01

The PB ratio of Genesis IBRC India is 15.2 As on 02 April, 2026 | 15:01

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23